Adel Aitali, DPM
Podiatry · Davis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 10 years
- Western University of Health Sciences College of Dental Med, 2016
Offices
1 location · Basso Podiatry Group Inc · 5 clinicians in this group
Hospitals listed: Sutter Davis Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aitali’s office at (530) 758-1810 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Davis HospitalDavis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Sutter Davis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 247 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.43 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 857 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,791 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.6 to 16.4) · 878 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 240 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$283,213
Medicare paid this office $283,213 for 484 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 207 | $36,333 | $101 |
| Removal of fingernails or toenails, 6 or more nails | 179 | $22,479 | $36 |
| Removal of noncancer thickened skin growth, 2-4 growths | 147 | $21,354 | $65 |
| Short return visit (20+ min) | 179 | $18,791 | $71 |
| Removal of noncancer thickened skin growth, 1 growth | 122 | $12,052 | $57 |
See all 16 services
| Return visit (30+ min) | 207 | $36,333 | $101 |
| Removal of fingernails or toenails, 6 or more nails | 179 | $22,479 | $36 |
| Removal of noncancer thickened skin growth, 2-4 growths | 147 | $21,354 | $65 |
| Short return visit (20+ min) | 179 | $18,791 | $71 |
| Removal of noncancer thickened skin growth, 1 growth | 122 | $12,052 | $57 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $10,512 | $106 |
| New patient visit (30+ min) | 109 | $8,903 | $82 |
| Removal of noncancer thickened skin growth, more than 4 growths | 47 | $6,807 | $73 |
| New patient visit (45+ min) | 47 | $6,071 | $129 |
| Removal of fingernails or toenails, 1-5 nails | 47 | $4,304 | $25 |
| Long return visit (40+ min) | 27 | $4,150 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,749 | $137 |
| X-ray of foot, minimum of 3 views | 71 | $2,460 | $27 |
| Trimming of dystrophic nails, any number | 38 | $2,193 | $15 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $625 | $52 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 16 | $128 | None |
Procedures Medicare counted
| Removal of nail tissue | 871 | More than 90% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 135 | More than 88% of doctors who do this |
| Removal or shaving of skin growth | 529 | More than 96% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of fingernails or toenails, 6 or more nails | – | 55 | 201 | 485 | 557 | 628 |
| Removal of noncancer thickened skin growth, 2-4 growths | – | 44 | 95 | 164 | 287 | 331 |
| Removal of noncancer thickened skin growth, 1 growth | – | 12 | 27 | 128 | 187 | 211 |
| Removal of fingernails or toenails, 1-5 nails | – | 89 | 22 | 32 | 156 | 169 |
| Removal of skin and tissue, 20.0 sq cm or less | – | 47 | 40 | – | 165 | 99 |
| Removal of noncancer thickened skin growth, more than 4 growths | – | – | – | 15 | 70 | 93 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
484 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 19% · Women 57% · Also on Medicaid 26% · Health risk score 1.73. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 73% · Diabetes 45% · Chronic kidney disease 34% · Coronary heart disease 25% · Depression 24% · Heart failure 22% · Atrial fibrillation 22% · Cancer 15% · COPD 12% · Stroke 8% · Dementia 7%.
The office billed $705,461, Medicare allowed $369,339 and paid $283,213; for 2,878 services of 50 kinds; $104,341 of it was for drugs given in the office and $178,872 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 484 | 2,878 | 76 | 1.73 | $705,461 | $283,213 |
| 2023 | 426 | 2,906 | 76 | 1.69 | $772,010 | $324,660 |
| 2022 | 528 | 2,193 | 75 | 1.70 | $538,737 | $195,444 |
| 2021 | 649 | 1,635 | 75 | 1.76 | $461,612 | $180,633 |
| 2020 | 547 | 1,651 | 75 | 2.24 | $364,334 | $127,014 |
| 2019 | 101 | 122 | 75 | 2.07 | $26,400 | $10,387 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 221 | $29,564 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 181 | $19,363 | $35 |
| Removal of noncancer thickened skin growth, 2-4 growths | 132 | $18,438 | $64 |
| Return visit (30+ min) | 110 | $16,926 | $103 |
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $16,760 | $102 |
| Removal of noncancer thickened skin growth, 1 growth | 114 | $11,179 | $60 |
| New patient visit (30+ min) | 112 | $9,202 | $82 |
| New patient visit (45+ min) | 53 | $6,696 | $126 |
| Removal of noncancer thickened skin growth, more than 4 growths | 34 | $5,045 | $72 |
| Removal of fingernails or toenails, 1-5 nails | 67 | $4,195 | $27 |
| X-ray of foot, minimum of 3 views | 75 | $2,919 | $28 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,539 | $141 |
| Trimming of dystrophic nails, any number | 54 | $2,435 | $18 |
| X-ray of ankle, minimum of 3 views | 11 | $420 | $30 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $103 | None |
2022: 14 services
| Short return visit (20+ min) | 205 | $25,738 | $68 |
| Removal of fingernails or toenails, 6 or more nails | 152 | $16,521 | $34 |
| Return visit (30+ min) | 152 | $15,785 | $88 |
| New patient visit (30+ min) | 159 | $12,015 | $76 |
| Removal of noncancer thickened skin growth, 2-4 growths | 88 | $10,452 | $64 |
| New patient visit (45+ min) | 80 | $10,067 | $126 |
| Removal of noncancer thickened skin growth, 1 growth | 80 | $7,218 | $56 |
| X-ray of foot, minimum of 3 views | 108 | $4,320 | $26 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,244 | $147 |
| Removal of noncancer thickened skin growth, more than 4 growths | 12 | $1,173 | $78 |
| Injection into tendon at attachment to bone or muscle | 14 | $875 | $42 |
| X-ray of ankle, minimum of 3 views | 16 | $864 | $30 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $715 | $22 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 17 | $122 | None |
2021: 12 services
| Return visit (30+ min) | 192 | $27,871 | $102 |
| New patient visit (45+ min) | 189 | $24,881 | $132 |
| Short return visit (20+ min) | 164 | $16,768 | $70 |
| New patient visit (30+ min) | 124 | $10,528 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 132 | $7,260 | $36 |
| Removal of noncancer thickened skin growth, 2-4 growths | 78 | $6,260 | $66 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $3,867 | $97 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $3,436 | $104 |
| X-ray of foot, minimum of 3 views | 47 | $1,667 | $27 |
| Removal of noncancer thickened skin growth, 1 growth | 25 | $1,580 | $59 |
| Removal of fingernails or toenails, 1-5 nails | 16 | $623 | $28 |
| Trimming of dystrophic nails, any number | 11 | $239 | $18 |
2020: 12 services
| Return visit (30+ min) | 204 | $31,227 | $90 |
| New patient visit (45+ min) | 163 | $21,305 | $131 |
| New patient visit (30+ min) | 142 | $11,473 | $81 |
| Short return visit (20+ min) | 77 | $8,100 | $63 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $4,570 | $97 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $3,635 | $87 |
| Removal of noncancer thickened skin growth, 2-4 growths | 44 | $2,538 | $58 |
| Removal of fingernails or toenails, 1-5 nails | 89 | $2,337 | $26 |
| Removal of fingernails or toenails, 6 or more nails | 55 | $1,772 | $32 |
| Trimming of dystrophic nails, any number | 88 | $1,225 | $14 |
| X-ray of foot, minimum of 3 views | 18 | $844 | $25 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $615 | $51 |
2019: 3 services
| Return visit (30+ min) | 52 | $5,319 | $90 |
| New patient visit (30+ min) | 40 | $3,576 | $89 |
| Short return visit (20+ min) | 19 | $1,356 | $62 |
Medicaid work
$25,471 in 2024
Medicaid paid $25,471 for 781 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 287 | $10,955 |
| Debridement of nail(s) by any method(s); 6 or more | 210 | $5,236 |
| Short return visit (20+ min) | 167 | $3,860 |
| New patient visit (30+ min) | 43 | $2,907 |
| New patient visit (45+ min) | 13 | $1,319 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 61 | $1,194 |
| 2024 | 781 | 6 | 34 | $25,471 |
| 2023 | 627 | 5 | 39 | $15,597 |
| 2022 | 622 | 7 | 31 | $14,370 |
| 2021 | 190 | 3 | 16 | $2,801 |
| 2020 | 200 | 5 | 20 | $2,793 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 288 | $6,760 |
| Return visit (30+ min) | 139 | $4,641 |
| Debridement of nail(s) by any method(s); 6 or more | 158 | $3,662 |
| X-RAY EXAM OF FOOT | 29 | $387 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 13 | $148 |
2022
| Short return visit (20+ min) | 239 | $4,977 |
| Return visit (30+ min) | 99 | $2,283 |
| Debridement of nail(s) by any method(s); 6 or more | 121 | $2,277 |
| New patient visit (30+ min) | 39 | $2,224 |
| New patient visit (45+ min) | 14 | $1,231 |
| X-RAY EXAM OF FOOT | 98 | $1,230 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 12 | $147 |
2021
| Short return visit (20+ min) | 88 | $2,496 |
| Return visit (30+ min) | 72 | $167 |
| New patient visit (45+ min) | 30 | $138 |
2020
| Short return visit (20+ min) | 87 | $2,107 |
| X-RAY EXAM OF FOOT | 31 | $403 |
| Return visit (30+ min) | 51 | $192 |
| New patient visit (30+ min) | 19 | $57 |
| New patient visit (45+ min) | 12 | $34 |
Drugs they prescribed that Part D paid
$3,140
Pharmacies billed $3,140 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
148 generic and fewer than 11 brand-name prescriptions · $3,140 in drug cost · 33 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clotrimazole | 59 | $1,690 | $29 |
| Clotrimazole-Betamethasone | 24 | $444 | $18 |
| Cephalexin | 22 | $258 | $12 |
Year by year
| 2024 | 152 | 81 | None | None | $3,140 |
| 2023 | 113 | 65 | None | None | $3,891 |
| 2022 | 100 | 58 | None | None | $2,806 |
| 2021 | 128 | 69 | 10% (13) | None | $3,411 |
| 2020 | 192 | 84 | 16% (31) | None | $7,271 |
| 2019 | 48 | 32 | None | None | $3,084 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Clotrimazole | 49 | $2,048 | $42 |
| Clotrimazole-Betamethasone | 18 | $212 | $12 |
| Cephalexin | 12 | $114 | $10 |
2022: 4 drugs
| Clotrimazole | 36 | $1,458 | $41 |
| Ciclopirox | 13 | $890 | $68 |
| Clotrimazole-Betamethasone | 13 | $114 | $9 |
| Cephalexin | 11 | $74 | $7 |
2021: 4 drugs
| Clotrimazole | 15 | $660 | $44 |
| Ciclopirox | 15 | $445 | $30 |
| Diclofenac | 21 | $378 | $18 |
| Doxycycline Hyclate | 11 | $196 | $18 |
2020: 5 drugs
| Clotrimazole | 41 | $2,118 | $52 |
| Ketoconazole | 17 | $1,126 | $66 |
| Diclofenac | 36 | $848 | $24 |
| Hydrocodone-Acetaminophen | 25 | $357 | $14 |
| Clotrimazole-Betamethasone | 11 | $283 | $26 |
Money from drug and device companies
$1,561 in 2025
| 2025 | 7 | 22 | None | $1,561 |
| 2024 | 6 | 20 | None | $970 |
| 2023 | 3 | 9 | None | $849 |
| 2022 | 4 | 7 | None | $1,369 |
| 2021 | 3 | 8 | None | $313 |
| 2020 | 4 | 5 | None | $77 |
| 2019 | 11 | 28 | None | $6,060 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Evolution Surgical | None | $407 | 1 payment
|
| Arthrex | None | $339 | 5 payments
|
| MIMEDX Group | None | $312 | 10 payments
|
| Amgen | Krystexxa | $150 | 1 payment
|
| Treace Medical Concepts | None | $146 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $128 | 2 payments
|
See all 22 published payments
| Amgen | Meals · 2025-12-09 | Krystexxa | $150 |
| Evolution Surgical | Travel · 2025-11-30 | None | $407 |
| MIMEDX Group | Meals · 2025-10-08 | None | $38 |
| Arthrex | Travel · 2025-09-11 | None | $207 |
| Bioventus | Meals · 2025-08-26 | Exogen Ultrasound Bone Healing System | $28 |
| Bioventus | Meals · 2025-08-20 | Exogen Ultrasound Bone Healing System | $101 |
| Arthrex | Meals · 2025-07-31 | None | $36 |
| Arthrex | Meals · 2025-07-31 | None | $30 |
| Arthrex | Meals · 2025-07-31 | None | $36 |
| Arthrex | Meals · 2025-07-31 | None | $30 |
| MIMEDX Group | Meals · 2025-07-30 | None | $39 |
| MIMEDX Group | Meals · 2025-07-02 | None | $38 |
| Treace Medical Concepts | Meals · 2025-06-05 | None | $44 |
| MIMEDX Group | Meals · 2025-06-02 | None | $14 |
| MIMEDX Group | Meals · 2025-05-20 | None | $42 |
| MIMEDX Group | Meals · 2025-04-14 | None | $37 |
| Stryker | Meals · 2025-03-19 | Prostep Mica | $79 |
| MIMEDX Group | Meals · 2025-02-21 | None | $43 |
| MIMEDX Group | Meals · 2025-02-21 | None | $5 |
| MIMEDX Group | Meals · 2025-02-13 | None | $15 |
| MIMEDX Group | Meals · 2025-01-23 | None | $41 |
| Treace Medical Concepts | Meals · 2025-01-22 | None | $102 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $970
| MIMEDX Group | None | $276 | 14 payments
|
| Stryker | Actishield | $173 | 1 payment
|
| Avita Medical Americas | Recell | $142 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $131 | 1 payment
|
| Evolution Surgical | None | $128 | 2 payments
|
| Paragon 28 | Precision Mis Bunion | $120 | 1 payment
|
2023: $849
| Musculoskeletal Transplant Foundation | None | $651 | 3 payments
|
| Treace Medical Concepts | Lapiplasty System | $173 | 5 payments
|
| Stryker | Na | $25 | 1 payment
|
2022: $1,369
| Sequoia Surgical | None | $1,218 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $101 | 3 payments
|
| Stryker | Prostep | $34 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
2021: $313
| Stryker | Prophecy | $177 | 2 payments
|
| Medline Industries | Hyalomatrix Wound Device | $107 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $28 | 5 payments
|
2020: $77
| Acell | None | $32 | 2 payments
|
| Integra LifeSciences | Omnigraft | $22 | 1 payment
|
| Axogen | Avance Nerve Graft | $11 | 1 payment
|
| Kci USA | Snap | $11 | 1 payment
|
2019: $6,060
| Micromed | None | $2,649 | 1 payment
|
| Acell | None | $1,080 | 5 payments
|
| Paragon 28 | None | $870 | 5 payments
|
| Treace Medical Concepts | Lapiplasty System | $428 | 3 payments
|
| Medical Device Business Services | None | $315 | 1 payment
|
| Medline Industries | Dermatology and Wound Care | $257 | 4 payments
|
| Crossroads Extremity Systems | None | $240 | 2 payments
|
| Integra LifeSciences | Bilayer Wound Matrix (Bwm) | $118 | 1 payment
|
| Organogenesis | Apligraf | $66 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $24 | 2 payments
|
| Merck Sharp & Dohme | Sivextro | $13 | 1 payment
|
Checkups this office reported
17 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 89.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 52%That's more than half. | 27 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 60%That's more than half. | 293 |
| Breast cancer screeningEligible women who got a mammogram | 64%That's more than half. | 278 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 42%That's less than half. | 258 |
| Checked for fall riskOlder patients screened for fall risk | 6%That's few of the people this applied to. | 555 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 24% | 25 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 0% | 40 |
| Colon cancer screeningEligible adults who got a colon cancer test | 54%That's more than half. | 531 |
See the other 9 measures
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 19%That's few of the people this applied to. | 828 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 42%That's less than half. | 203 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 45%That's less than half. Better on this measure. | 203 |
| Medications listed in the chartVisits where the current medication list was documented | 4%That's few of the people this applied to. | 2,714 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 98%That's most of the people this applied to. | 1,384 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 268 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 15%That's few of the people this applied to. Better on this measure. | 549 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 1% | 1,431 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 30%That's less than half. | 1,072 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Enabling Exchange Under TEFCA
- Glycemic Referring Services
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Offers telehealth visits
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Reports to a public-health or clinical registry
Professional record
- NPI
- 1720518129
- Licence
- CA EL6778
- Trained
- Western University of Health Sciences College of Dental Med, 2016 · 10 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 635 Anderson Rd Ste 19, Davis, CA, 95616
- NPI first listed
- 2017-06-18
- NPI last updated
- 2022-05-23
- NPI record certified
- 2022-05-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 635 Anderson Rd Ste 19, Davis, CA, 95616